apceth to Manufacture First Potential One-Time Gene Therapy for Transfusion-Dependent Beta-Thalassemia
Munich, Germany, October 05, 2018 / B3C newswire / -- apceth Biopharma GmbH, a leading company for the development and manufacturing of cell and gene therapeutics, congratulates its partner bluebird bio on the acceptance and validation of its market …